FDA Accepts Casimersen NDA for Patients with Exon 45 Amenable DMD

Earlier this week, Sarepta Therapeutics announced that the FDA approved a New Drug Application (NDA) for Casimersen (SRP-4045). The treatment, for patients with exon 45 amenable Duchenne muscular dystrophy (DMD),…

Continue Reading FDA Accepts Casimersen NDA for Patients with Exon 45 Amenable DMD
Company Obtains Patent for Hepatocellular Carcinoma Combination Treatment
source: pixabay.com

Company Obtains Patent for Hepatocellular Carcinoma Combination Treatment

According to a story from BioSpace, the biotechnology company Tiziana Life Sciences plc has announced that it was recently granted a patent from the United States Patent and Trademark Office…

Continue Reading Company Obtains Patent for Hepatocellular Carcinoma Combination Treatment

An Experimental Drug for Alzheimer’s is Being Tested to Treat Autism

Professor Illana Gozes and her team at Tel Aviv University recently developed NAP (CP201). It is an experimental drug that has been proven to be effective in the treatment of…

Continue Reading An Experimental Drug for Alzheimer’s is Being Tested to Treat Autism
Close Menu